Helminthic infections of the liver

Current Gastroenterology Reports

Volumn 6, Issue 4, 2004, Pages 287-296

  Pockros, Paul J ^a   Capozza, Thomas A ^b  

^a SCRIPPS CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BIOTHIONOL; CORTICOSTEROID; DEHYDROEMETINE; DIETHYLCARBAMAZINE; INTERFERON; IVERMECTIN; MEBENDAZOLE; OXAMNIQUINE; PIPERAZINE CITRATE; PRAZIQUANTEL; PREDNISONE; RIBAVIRIN; SCHISTOSOMA VACCINE; TIABENDAZOLE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ASCARIASIS; ASCARIS LUMBRICOIDES; CESTODE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL; CLONORCHIS SINENSIS; DRUG HALF LIFE; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; ECHINOCOCCUS MULTILOCULARIS; FASCIOLA GIGANTICA; FASCIOLA HEPATICA; FASCIOLIASIS; GASTROINTESTINAL SYMPTOM; HELMINTH; HELMINTHIASIS; HEPATITIS; HEPATITIS C; HEPATOBILIARY SYSTEM INFECTION; HUMAN; IMMUNE RESPONSE; LIVER CIRRHOSIS; LIVER DISEASE; MASS SCREENING; MORBIDITY; MORTALITY; NEMATODE; NONHUMAN; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; REVIEW; SCHISTOSOMA INTERCALATUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TOXOCARA CANIS; TOXOCARIASIS; TREMATODE;

EID: 4344587706     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-004-0080-8     Document Type: Review

References (50)

1. Khuroo MS: Ascariasis. Gastroenterol Clin North Am 1996, 25(3):553-578.
2. DiazGranados CA, Duffus WA, Albrecht H: Parasitic diseases of the liver. In Hepatology: A Textbook of Liver Disease. Edited by Zakim D, Boyer TD. Philadelphia: WB Saunders; 2002:1073-1107.
3. Sarinas PS, Chitkara RK: Ascariasis and hookworm. Semin Respir Infect 1997, 12:130-137.
4. Thein-Hliang: A profile of ascariasis morbidity in Rangoon Children's Hospital, Burma. J Trop Med Hyg 1987, 90:165-169.
5. World Health Organization: Intestinal protozoan and helminthic infections: report of a WHO scientific group. In Geneva, Switzerland: World Health Organization; 1981. WHO Technical Report Series 666.
6. Seltzer E, Barry M: Ascariasis. In Tropical Infectious Diseases: Principles, Pathogens and Practice. Edited by Guerrant RL, Walker DH, Weller PF. Philadelphia: Churchill Livingstone; 1999:959-965.
7. Khuroo MS, Zargar SA, Mahajan R: Hepatobiliary and pancreatic ascariasis in India. Lancet 1990, 335:1503-1506.
8. Schulman A: Intrahepatic biliary stones: imaging features and a possible relationship with Ascaris lumbricoides. Clin Radiol 1993, 47:325-332.
9. Fogaca HS, Oliveira CS, Barbarosa HT, et al.: Liver pseudotumor: a rare manifestation of hepatic granulomata caused by Ascaris lumbricoides ova. Am J Gastroenterol 2000, 95:2099-2101.
10. Ryan ET, Wilson ME, Kain KC: Illness after international travel. N Engl J Med 2002, 347:505-516.
11. Sandouk F, Haffar S, Zada MM, et al.: Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol 1997, 92:2264-2268.
12. Albonico M, Smith PG, Hall A: A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Trans R Soc Trop Med Hyg 1994, 88:585-589.
13. Liu LX, Weller PF: Antiparasitic drugs. N Engl J Med 1996, 334:1178-1184.
14. Dunn MA: Parasitic diseases. In Schiff's Diseases of the Liver. Edited by Schiff ER, Sorrell MF, Maddrey WC. Philadelphia: Lippincott Williams & Wilkins; 2003:1509-1527.
15. Marques de Oliveira LC, Toffoli-Ribeiro C, de Melo Mendes D, et al.: Frequency of Strongyloides stercoralis infection in alcoholics. Mem Inst Oswaldo Cruz 2002, 97:119-121.
16. Parana R, Portugal M, Vitvitski L: Severe strongyloidiasis during interferon plus ribavirin therapy for chronic HCV infection. Eur J Gastroenterol Hepatol 2000, 12:245-246.
17. Atkins NS, Conway DJ, Lindo JF, et al.: L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output. Parasite Immunol 1999, 21:517-526.
18. Tsai HC, Lee SS, Liu YC, et al.: Clinical manifestations of strongyloidiasis in southern Taiwan. J Microbiol Immunol Infect 2002, 35:29-36.
19. Sato Y, Kobayashi J, Toma H, Shiroma Y: Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995, 53:248-250.
20. van der Feltz M, Slee PH, van Hees PA, et al.: Strongyloides stercoralis infection: how to diagnose best? Neth J Med 1999, 55:128-131.
21. Drugs for parasitic infections. The Medical Letter on Drugs and Therapeutics. http://www.medletter.com/
22. Hanck C, Hatz C: Treatment of Strongyloides infections [letter]. Gastroenterology 2000, 119:1805.
23. Liu LX, Weller PF, Nutman TB, et al.: Helminthic infections. In Harrison's Principles of Internal Medicine. Edited by Braunwald E, Fauci AS, Kasper DL, et al. New York: McGraw-Hill; 2001:1231-1248.
24. Schantz PM: Toxocariasis. In Hunter's Tropical Medicine and Emerging Infectious Diseases. Edited by Strickland DT. Philadelphia: WB Saunders; 2000:787-790.
25. Rai SK, Uga S, Wu Z, et al.: Use of polymerase chain reaction in the diagnosis of toxocariasis: an experimental study. Southeast Asian J Trop Med Pub Health 1997, 28:541-544.
26. Govil H, Desai M: Capillaria hepatica parasitism. Indian J Pediatr 1996, 63:698-700.
27. Terrier P, Hack I, Hatz C, et al.: Hepatic capillariasis in a 2-year-old boy. J Pediatr Gastroenterol Nutr 1999, 28:338-340.
28. Craig PS, Giraudoux P, Shi D, et al.: An epidemiological and ecological study of human alveolar echinococcosis transmission in south Gansu, China. Acta Trop 2000, 77:167-177.
29. Ammann RW, Eckert J: Cestodes. Gastroenterol Clin North Am 1996, 25:655-689.
30. Craig PS: Echinococcus multilocularis. Curr Opin Infect Dis 2003, 16:437-444.
31. Vuitton DA, Bresson-Hadni S, Laroche L, et al.: Cellular immune response in Echinococcus multilocularis infection in humans II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol 1989, 78:67-74.
32. Gelman R, Brook G, Green J, et al.: Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol 2000, 53:152-155.
33. Suwan Z: Sonographic findings in hydatid disease of the liver: comparison with other imaging methods. Ann Trop Med Parasitol 1995, 89:261-269.
34. Kervancioglu R, Bayram M, Elbeyli L: CT findings in pulmonary hydatid disease. Acta Radiol 1999, 40:510-514.
35. Silas-Lucas M, Gottstein B: Molecular tools for the diagnosis of cystic and alveolar echinococcosis. Trop Med Int Health 2001, 6:463-475.
36. Bresson-Hadni S, Koch S, Beurton I, et al.: Primary disease recurrence after liver transplantation for alveolar echinococcis: long-term evaluation of 15 patients. Hepatology 1999, 30:857-864.
37. Simsek H, Ozaslan E, Sayek I, et al.: Diagnostic and therapeutic ERCP in hepatic hydatid disease. Gastrointest Endosc 2003, 58:384-389.
38. World Health Organization: Communicable Disease Surveillance and Response: PAIR: Puncture, Aspiration, Injection, Re-Aspiration. http://www.who.int/emc-documents/zoonoses/whocdscsraph20016.html. Accessed March 2004.
39. Reuter S, Buck A, Burkhard M, et al.: Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004, 39:509-517.
40. Echinonet, on line version of Echinonews: Newsletter of the WHO Informal Working Group on Echinococcosis. http://www.medicalweb.it/aumi/echinonet Accessed March 2004.
41. Heath DD, Jensen O, Lightowlers MW: Progress in control of hydatidosis using vaccination: a review of formulation and delivery of the vaccine and recommendations for the practical use in control programmes. Acta Trop 2003, 85:133-143.
42. Roig GV: Hepatic fascioliasis in the Americas: a new challenge for therapeutic endoscopy. Gastrointest Endosc 2002, 56:315-317.
43. Dowidar N, El Sayad M, Osman M, Salem A: Endoscopic therapy of fascioliasis resistant to oral therapy. Gastrointest Endosc 1999, 50:345-351.
44. Bunnag D, Cross JH, Bunnag T: Liver fluke infections. In Hunter's Tropical Medicine and Emerging Infectious Diseases. Edited by Strickland DT. Philadelphia: WB Saunders; 2000:840-846.
45. Ross AG, Bartley PB, Sleigh AC, et al.: Schistosomiasis. N Engl J Med 2002, 346:1212-1220.
46. Bica I, Hamer DH, Stadecker MJ: Hepatic schistosomiasis. Infect Dis Clin North Am 2000, 14:583-604.
47. Strickland DT, Ramirez BL: Schistosomiasis. In Hunter's Tropical Medicine and Emerging Infectious Diseases. Edited by Strickland DT. Philadelphia: WB Saunders; 2000:804-832.
48. Sharma S: Granulomatous diseases of the liver. In Hepatology: A Textbook of Liver Disease. Edited by Zakim D, Boyer TD, Walton RE. Philadelphia: WB Saunders; 2002:1317-1330.
49. Stanton RE: Developments in schistosomiasis research and management. Curr Opin Infect Dis 2000, 13:445-450.
50. Capron A, Capron M, Dombrowicz D, Riveau G: Vaccine strategies against schistosomiasis: from concepts to clinical trials. Int Arch Allergy Immunol 2001, 124:9-15.